This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: Yale University. Active years: 2021-2024.
Company Filing History:
Years Active: 2021-2024
Title: David Rawling: Innovator in RNA Technology
Introduction
David Rawling is a prominent inventor based in San Mateo, CA (US). He has made significant contributions to the field of RNA technology, particularly in the area of interferon production. With a total of 2 patents, his work has the potential to impact various applications in biotechnology and medicine.
Latest Patents
David Rawling's latest patents focus on the production of interferon using short RNA duplexes. The first patent presents a small hairpin nucleic acid molecule that is capable of stimulating interferon production. This nucleic acid molecule features a double-stranded section of less than 19 base pairs and at least one blunt end. In certain embodiments, the molecule comprises a 5′ triphosphate or a 5′ diphosphate. This innovative approach could lead to advancements in therapeutic applications.
Career Highlights
David Rawling is affiliated with Yale University, where he continues to explore the potential of RNA technology. His research has garnered attention for its innovative methodologies and applications in the field of molecular biology. His work is characterized by a commitment to advancing scientific knowledge and practical applications.
Collaborations
David has collaborated with notable researchers, including Anna Marie Pyle and Andrew Kohlway. These collaborations have enriched his research and contributed to the development of groundbreaking technologies in RNA production.
Conclusion
David Rawling is a key figure in the field of RNA technology, with a focus on interferon production. His innovative patents and collaborations highlight his commitment to advancing scientific research and its applications. His contributions are poised to make a significant impact in biotechnology and medicine.